These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
240 related articles for article (PubMed ID: 18690941)
1. Drug-induced hair disorders. Piraccini BM; Iorizzo M; Rech G; Tosti A Curr Drug Saf; 2006 Aug; 1(3):301-5. PubMed ID: 18690941 [TBL] [Abstract][Full Text] [Related]
2. Drug reactions affecting hair: diagnosis. Tosti A; Pazzaglia M Dermatol Clin; 2007 Apr; 25(2):223-31, vii. PubMed ID: 17430759 [TBL] [Abstract][Full Text] [Related]
3. Drug-induced hair loss and hair growth. Incidence, management and avoidance. Tosi A; Misciali C; Piraccini BM; Peluso AM; Bardazzi F Drug Saf; 1994 Apr; 10(4):310-7. PubMed ID: 8018303 [TBL] [Abstract][Full Text] [Related]
4. [Adverse drug reactions on hair]. Gollnick H; Blume U; Orfanos CE Z Hautkr; 1990 Dec; 65(12):1128-34. PubMed ID: 2087842 [TBL] [Abstract][Full Text] [Related]
5. 'Atrophic telogen effluvium' from cytotoxic drugs and a randomized controlled trial to investigate the possible protective effect of pretreatment with a topical vitamin D analogue in humans. Bleiker TO; Nicolaou N; Traulsen J; Hutchinson PE Br J Dermatol; 2005 Jul; 153(1):103-12. PubMed ID: 16029334 [TBL] [Abstract][Full Text] [Related]
7. Drug-induced hair colour changes. Ricci F; De Simone C; Del Regno L; Peris K Eur J Dermatol; 2016 Dec; 26(6):531-536. PubMed ID: 27545142 [TBL] [Abstract][Full Text] [Related]
8. Drugs and hair loss. Patel M; Harrison S; Sinclair R Dermatol Clin; 2013 Jan; 31(1):67-73. PubMed ID: 23159177 [TBL] [Abstract][Full Text] [Related]
9. Hair and systemic disease. Sperling LC Dermatol Clin; 2001 Oct; 19(4):711-26, ix. PubMed ID: 11705356 [TBL] [Abstract][Full Text] [Related]
10. Topical odorant application of the specific olfactory receptor OR2AT4 agonist, Sandalore Jimenez F; López E; Bertolini M; Alam M; Chéret J; Westgate G; Rinaldi F; Marzani B; Paus R J Cosmet Dermatol; 2021 Mar; 20(3):784-791. PubMed ID: 32645251 [TBL] [Abstract][Full Text] [Related]
11. Acute telogen effluvium onset event is associated with the presence of female androgenetic alopecia: potential therapeutic implications. Perez-Mora N; Goren A; Velasco C; Bermudez F Dermatol Ther; 2014; 27(3):159-62. PubMed ID: 24850277 [TBL] [Abstract][Full Text] [Related]
12. Hair loss and hirsutism in the elderly. Hordinsky M; Sawaya M; Roberts JL Clin Geriatr Med; 2002 Feb; 18(1):121-33, vii. PubMed ID: 11913736 [TBL] [Abstract][Full Text] [Related]
13. Telogen effluvium revisited. Rebora A G Ital Dermatol Venereol; 2014 Feb; 149(1):47-54. PubMed ID: 24566565 [TBL] [Abstract][Full Text] [Related]
14. A Rare Type of Radiation-Induced Alopecia: Proton-Induced Alopecia. Fattore D; Picone V; Vastarella M; Fabbrocini G; Cantelli MT Skin Appendage Disord; 2023 Aug; 9(4):280-283. PubMed ID: 37564686 [TBL] [Abstract][Full Text] [Related]
15. Influence of prostaglandin F2alpha and its analogues on hair regrowth and follicular melanogenesis in a murine model. Sasaki S; Hozumi Y; Kondo S Exp Dermatol; 2005 May; 14(5):323-8. PubMed ID: 15854125 [TBL] [Abstract][Full Text] [Related]
16. Hair, nail, and pigment changes in major systemic disease. Ramos-e-Silva M; Chaves Azevedo-e-Silva M; Carneiro SC Clin Dermatol; 2008; 26(3):296-305. PubMed ID: 18640527 [TBL] [Abstract][Full Text] [Related]